AVAH

Aveanna Healthcare Holdings Inc. (AVAH) SWOT Analysis Analysis (2026)

Invetso Score: 4.4/10 — Balanced · Last Updated: 2026-08-01

Strengths

ROIC of 15.3% indicates capital deployment is earning above-cost returns, supporting peer-relative value creation despite Avah's smaller scale versus larger home-health operators.

A current ratio of 1.16 shows near-term liquidity is adequate, reducing refinancing pressure relative to more levered peers with tighter working-capital cushions.

Cash conversion cycle of 41.1 days suggests manageable cash tied up in operations, which can support working-capital discipline versus peers with longer collection cycles.

Weaknesses

Net debt to EBITDA of 4.6x signals elevated leverage, limiting strategic flexibility and leaving Avah structurally weaker than less levered peers in a higher-rate environment.

Debt-to-equity of 5.2x indicates a heavily debt-funded capital structure, which constrains reinvestment capacity relative to peers with stronger balance-sheet optionality.

A current ratio of 1.16 is only modestly above 1.0, so liquidity headroom remains thin versus peers with stronger short-term coverage.

The 41.1-day cash conversion cycle still reflects meaningful working-capital drag, making Avah less efficient than peers with faster cash realization.

Opportunities

If Avah sustains its 15.3% ROIC, it can compound value faster than lower-return peers by reinvesting in higher-yield service lines and local market density.

Improving working-capital efficiency from a 41.1-day cash conversion cycle could free cash for deleveraging, strengthening peer-relative financial flexibility over time.

With liquidity above 1.0, incremental operating improvements can translate into balance-sheet repair more quickly than at peers already constrained by acute short-term stress.

Threats

High leverage leaves Avah more exposed than peers to reimbursement pressure or volume softness, because fixed financing costs absorb a larger share of operating cash flow.

If interest rates remain elevated, refinancing risk stays higher than for peers with lower net debt to EBITDA, which can compress equity value and strategic optionality.

Working-capital needs can rise if collections slow, and Avah's modest liquidity buffer offers less protection than peers with stronger current ratios.

Overall Score

Avah shows acceptable capital returns and workable liquidity, but its elevated leverage and limited balance-sheet flexibility leave it structurally weaker than stronger-capitalized peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Aveanna Healthcare Holdings Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →